MIXED NON-ALBICANS CANDIDA FUNGEMIA: AN UNCOMMON BUT EASILY OVERLOOKED CLINICAL ENTITY
DOI:
https://doi.org/10.22159/ajpcr.2018.v11i11.28612Keywords:
Candida lipolytica, Candida tropicalis, Fluconazole, Non-albicans CandidaAbstract
The increasing use of invasive medical devices and broad-spectrum antimicrobial agents has resulted in rising candidemia rates throughout the world. A 70-year-old diabetic and schizophrenic woman was admitted initially for staphylococcal sepsis secondary to an infected sacral sore but developed a catheter-related bloodstream infection caused by extended-spectrum β-lactamase-producing Klebsiella sp. which necessitated the administration of meropenem. Unfortunately, after a week on the carbapenem, the bacterial sepsis was followed by candidemia. Parenteral fluconazole therapy was started pending identification of the yeast(s). Two distinct Candida species were isolated from her blood which were identified biochemically using ID 32 C as Candida tropicalis and Candida lipolytica. Both yeasts possessed elevated minimal inhibitory concentrations toward fluconazole and although amphotericin B was eventually administered, the patient succumbed to her illness.
Downloads
References
Delaloye J, Calandra T. Invasive candidiasis as a cause of sepsis in the critically ill patient. Virulence 2014;5:161-9.
Wisplinghoff H, Seifert H, Wenzel RP, Edmond MB. Inflammatory response and clinical course of adult patients with nosocomial bloodstream infections caused by Candida spp. Clin Microbiol Infect 2006;12:170-7.
Kaur R, Dhakad MS, Goyal R, Kumar R. Emergence of non-albicans Candida species and antifungal resistance in intensive care unit patients. Asian Pac J Trop Biomed 2016;6:455-60.
Krcmery V, Barnes AJ. Non-albicans Candida spp. Causing fungaemia: Pathogenicity and antifungal resistance. J Hosp Infect 2002;50:243-60.
Kothavade RJ, Kura MM, Valand AG, Panthaki MH. Candida tropicalis: Its prevalence, pathogenicity and increasing resistance to fluconazole. J Med Microbiol 2010;59:873-80.
Zhao Y, Chan JF, Tsang CC, Wang H, Guo D, Pan Y, et al. Clinical characteristics, laboratory identification, and in vitro antifungal susceptibility of Yarrowia (Candida) lipolytica isolates causing fungemia: A multicenter, prospective surveillance study. J Clin Microbiol 2015;53:3639-45.
Ding CH, Wahab AA, Muttaqillah NA, Tzar MN. Prevalence of albicans and non-albicans candiduria in a Malaysian medical centre. J Pak Med Assoc 2014;64:1375-9.
Jensen J, Muñoz P, Guinea J, RodrÃguez-Créixems M, Peláez T, Bouza E, et al. Mixed fungemia: Incidence, risk factors, and mortality in a general hospital. Clin Infect Dis 2007;44:e109-14.
Al-Rawahi GN, Roscoe DL. Ten-year review of candidemia in a canadian tertiary care centre: Predominance of non-albicans Candida species. Can J Infect Dis Med Microbiol 2013;24:e65-8.
Pulimood S, Ganesan L, Alangaden G, Chandrasekar P. Polymicrobial candidemia. Diagn Microbiol Infect Dis 2002;44:353-7.
Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, Ostrosky- Zeichner L, et al. Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis 2016;62:e1-50.
Dharajiya D, Jasani H, Khatrani T, Kapuria M, Pachchigar K, Patel P. Evaluation of antibacterial and antifungal activity of fenugreek (Trigonella foenum-graecum) extracts. Int J Pharm Pharm Sci 2016;8:212-7.
Pandey S. Antibacterial and antifungal activities of Ocimum gratissimum L. Int J Pharm Pharm Sci 2017;9:26-31.
Published
How to Cite
Issue
Section
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
